Report #2842630

Received May 26, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: WI
Recovered: Unknown
Vaccinated: Mar 25, 2025
Onset: Mar 25, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	3	UNK	—

Symptoms (1)

Extra dose administered

Symptom narrative

received a 3rd dose of Shingrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date) and Shingrix (received 2nd dose on an unknown date). On 25-MAR-2025, the patient received the 3rd dose of Shingrix. On 25-MAR-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: received a 3rd dose of Shingrix). The outcome of the extra dose administered was not applicable. Additional Information: GSK receipt date: 22-MAY-2025 The reporter reported that the patient completed her series of Shingrix (dates not provided). The reporter reported that on 25th March 2025 received a 3rd dose of Shingrix which led to, extra dose administered. No further information was obtained/provided.